Auxilium International Holdings, Inc., part of Endo International Plc, is an American company focused on pharmaceutical preparations.

BioSpecifics Technologies Corp., a biopharmaceutical company, is engaged in the development of an injectable collagenase for various indications primarily in the United States. It provides injectable collagenase under the XIAFLEX name for the treatment of Dupuytren’s contracture and Peyronie’s disease. The company also develops XIAFLEX injectable collagenase for frozen shoulder, cellulite, human lipoma, canine lipoma, and uterine fibroid indications, as well as for keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. The company was founded in 1957 and is headquartered in Lynbrook, New York.

Endo Global Ventures, a subsidiary of Endo International Plc, is a company headquartered in Bermuda. The firm deals in pharmaceuticals preparation.

Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of Regenerative Ophthalmology therapeutics. Ocata’s most advanced products are in clinical trials for the treatment of Stargardt’s macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. Ocata’s intellectual property portfolio includes pluripotent stem cell platforms – hESC and induced pluripotent stem cell (iPSC) – and other cell therapy research programs.

Guangdong Weitai Biotechnology Co., Ltd., established on 2015-11-04, The scope of business includes research on stem cell and immune cell biotechnology and its biological products,to develop,Production,Sales and Applications;Collection of stem cells and immune cells,Storage and custody services;Research on genetic detection technology and its reagent products and instruments,to develop,Production,Sales;Gene drug development;Cell and gene-related technology transfer,Technical Services,technical consulting,Technical Training;Clinical Laboratory Services;Biomedical Technology Research;Provide management program services for medical institutions;Import and export,Technology Import and Export.Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;Natural science research and experimental development;Technology intermediary service;Quality inspection technical service;outpatient department(Place);nursing home;trade agent;Wholesale of cosmetics and hygiene products;Western medicine wholesale;Wholesale of nutrition and health products;Wholesale of medical supplies and equipment;Retailing of cosmetics and hygiene products;Nutrition and Supplement Retailing;Biopharmaceutical Manufacturing;Cosmetic Manufacturing;Health food manufacturing;Nutritional Food Manufacturing;dairy manufacturing;Manufacturing of chemical raw materials;Chemical Reagent and Auxiliary Manufacturing.(above production,Manufacturing items limited to branch operations)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Saliai Stemcell Science & Technology Co., Ltd. engages in the provision of stem cell storage, health supplements, biological products, and related health management services. It involves in the production of regenerative medicine devices, medical nutrition supplements, and biological & medical cosmetic products. It operates a research and development platform which includes life bank, health management center, medical center, and medical cell center. The company was founded by Hai Jia Chen and Ming Jia Chen on July 7, 2009 and is headquartered in Guangzhou, China.

Beijing Jingmeng Hi-Tech Stem Cell Technology Co., Ltd., established on 2009-08-13, The business scope includes cell engineering and tissue engineering related products,cell therapy technology,cell antibody,Technology development of gene medicine,Technology Promotion,technology transfer,technical consulting;Home remote health management service;Community telehealth management service;sell cosmetics,self-developed products,Instrumentation,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),medical instrumentsIkind;Medical Research and Experimental Development;health management,Health Advisory(Except for medical treatment activities subject to approval);Medical Laboratory;clinical body fluid,blood specialty;clinical microbiology major;clinical chemistry laboratory;clinical immunization,Serology major;Clinical Cytomolecular Genetics Major(Limited to branch operations).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Xuzhou Cell Medical Co., Ltd., established on 2017-06-22, The business scope includes research and development of stem cell and immune cell therapy technology,Clinical Research and Clinical Translation;Development and production of cellular medicines;storage of cells and tissues;technology development in biotechnology,technology transfer,technical consulting,Technical Services;Research and development of biological products,production and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangzhou Saiao Biotechnology Co., Ltd., established on 2015-01-26, Business scope includes technical services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Human stem cell technology development and application;R&D and application of cell technology;

Chongqing Saiao Biotechnology Co., Ltd., established on 2014-11-28, Business scope includes general items:stem cell biotechnology(Except for special items),immune cell biotechnology,Technology development in the field of laboratory equipment technology,technical consulting,Technical Services,technology transfer;Cell Preparation and Storage Services(Except for special regulations of the state);Sales of chemical products and raw materials(Free of hazardous chemicals and precursor chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shandong Hualing Aoyuan Biotechnology Co., Ltd., established on 2018-10-24, Business scope includes general items:R&D and application of cell technology;Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Health Consulting Services(Does not include medical services);fitness and leisure activities;Information Consulting Service(Not including licensing information consulting services).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:medical service;Import and export;Technology Import and Export;food production[Branch operation];pharmaceutical production[Branch operation].(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shenzhen Sail Cell Technology Co., Ltd., established on 2013-04-28, Business scope includes general business items:Research and development of biological and cell product technology;Research and development of biotherapeutic technology,technical consulting;Sales of cell culture-related reagents;Domestic Trade.,The licensing program is:

Shenzhen Wingor Bio-technology Co., Ltd. engages in the research and development, and production of anti-tumor biological immune cell products. It offers chimeric antigen receptor T lymphocyte, clustered regulatory interspaced short palindromic repeat, mesenchymal stem cell, methyl triazeno imidazole carboxamide technology, and cryobiomedical technology. The company was founded on March 12, 2013 and is headquartered in Shenzhen, China.

Beijing Saiao Biotechnology Co., Ltd., established on 2013-07-18, Business scope includes stem cell and immune cell therapy technology,Laboratory Equipment Technology,Biotechnology,Technology development in the field of cell preparation and storage services,technology transfer,technical consulting,Technical Services;health management,Health Advisory(Except for medical treatment activities subject to approval);Sales of chemical products(Free of Hazardous Chemicals),cosmetic,medical instruments(I,IIkind);medical service.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Medical services and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

iCell is a cell biotechnology company that specializes in basic research and clinical applications of immune cells. The company focuses on stem cell and immune cell basic research and clinical translational application research, cell product development, production and quality assurance, preclinical cell therapy testing, clinical efficacy evaluation and prognostic analysis, and providing cell therapy to doctors and patients.

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

Beijing Bopin Bailai Biomedical Technology Co., Ltd., established on 2020-07-20, Business scope includes biotechnology promotion,technology development,technology transfer,Technical Services,technical consulting;Retail Class I Medical Devices,cosmetic;Medical Research and Experimental Development;health management,Health Advisory(Except for medical treatment activities subject to approval).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.).

Guangdong Fulund Biotechnology Co., Ltd., established on 2020-03-04, Business scope includes biotechnology extension services;Agriculture, forestry, animal husbandry and fishery technology extension services;Technology intermediary service;Veterinary Services;Testing service;Inspection and Quarantine Services;Other technology promotion service industry;Agricultural Science Research and Experimental Development;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Professional and auxiliary activities in fisheries;trade agent;Retailing of Pharmaceuticals for Animals;Wholesale of fishery products;Livestock and Fishery Feed Wholesale;Wholesale of medicine and medical equipment;Internet wholesale(Except for pre-approval items for industrial and commercial registration).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)